Study protocol: Investigation of the Delirium Observation Screening Scale (DOSS) for the routine detection of delirium in the care home setting: a prospective cohort study by Teale, EA et al.
Study protocol—investigation of the
Delirium Observation Screening Scale
(DOSS) for the routine detection of
delirium in the care home setting:
a prospective cohort study
Elizabeth Teale,1 John Young,1 Najma Siddiqi,2 Theresa Munyombwe,3
Jennifer Harrison,4 Marieke Schuurmanns5
To cite: Teale E, Young J,
Siddiqi N, et al. Study
protocol—investigation of the
Delirium Observation
Screening Scale (DOSS) for
the routine detection of
delirium in the care home
setting: a prospective cohort
study. BMJ Open 2016;6:
e009615. doi:10.1136/
bmjopen-2015-009615
▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2015-009615).
Received 3 August 2015
Revised 2 October 2015
Accepted 28 October 2015
For numbered affiliations see
end of article.
Correspondence to
Dr Elizabeth Teale;
Elizabeth.Teale@bthft.nhs.uk
ABSTRACT
Introduction: Delirium is a common and distressing
condition associated with frailty, dementia and
comorbidity. These are common in long-term care
settings. Residents in care homes are therefore at
particular risk of delirium. Despite this, methods to
detect delirium in care homes are lacking, with existing
diagnostic tools taking too long, or requiring specific
training to deliver. This limits their feasibility for use
for the routine detection of delirium by care home
staff. Routine screening for delirium in care homes
would allow timely attention to exacerbating factors to
attenuate the episode, and facilitate future research into
delirium in the care home environment.
Methods: Residents from 4 large care homes will be
asked to consent (or their consultees asked to provide
a declaration of agreement) to participate in the study.
Care home staff will administer the 25-item Delirium
Observation Screening Scale (DOSS)—a delirium
screening tool based on observed behaviours—and
this will be tested against the research standard
Confusion Assessment Method (CAM) administered by
trained research assistants performed two times per
week for all participating residents.
Analysis: Sensitivity, specificity, positive and negative
predictive values, likelihood ratios and a diagnostic OR
will be calculated for the detection of delirium with the
25-item DOSS. The feasibility of routine delirium
screening and the scaling properties of the 25-item
DOSS will also be explored.
Ethics and Dissemination: For residents lacking
capacity to participate, a consultee will be approached
for a declaration of agreement for inclusion in the
study. Results will be published in peer-reviewed
journals and disseminated in written format to clinical
commissioning groups, general practitioners and
relevant third parties.
Trial registration number: ISRCTN14608554.
INTRODUCTION
Delirium is a common and serious condition
characterised by a sudden onset of altered
cognition and impairments of attention,
thinking and alertness. These symptoms tend
to ﬂuctuate over days or hours and often
manifest as changes in behaviour. Delirium is
associated with increased risk of new or accel-
erated cognitive problems, functional decline
and death.1 Individuals suffering from an
episode of delirium often have an altered
perception of their surroundings and fre-
quently misinterpret their environment. This
may result in anxiety or unusual behaviours
which can be distressing and frightening for
the patient, their family and their carers.2
There are many risk factors for delirium,
for example: dementia, deafness, poor vision,
dehydration, pain, constipation and medica-
tions. These risk factors are prevalent in care
homes where residents may be frail with mul-
tiple comorbidities including dementia,
further increasing the risk of developing delir-
ium.3 A 2009 BUPA survey revealed that 44%
of care home residents had a diagnosis of
dementia, and 60% were classed as ‘frail
elderly’ at the time of death.4 It is therefore
anticipated that delirium should be a common
problem in residents of care homes. In 2010,
the National Institute for Health and Care
Excellence (NICE) guidelines for the diagno-
sis, prevention and management of delirium
highlighted the paucity of research literature
detailing the incidence and prevalence of
delirium in long-term care settings.5 This may
be, in part, due to the signiﬁcant challenges
in detecting delirium, and conducting re-
search in care homes. A simple, valid delirium
screening tool that can be reliably adminis-
tered by care home staff would improve delir-
ium detection and might also have utility for
future research into delirium in the care
home setting.
There are currently no laboratory tests or
biomarkers to establish the diagnosis. Detection
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of delirium relies on identifying sudden changes in an
individual’s behaviour from their baseline. Care home
staff are particularly well placed to detect these changes.
Existing diagnostic tools for detection of delirium
operationalise the diagnostic criteria of the Diagnostic
Manual for Mental Disorders, Fourth Edition
(DSM-IV).6 These tools require time and training to
administer which has limited their uptake into routine
care.
For an instrument to have utility for delirium detec-
tion in routine care in the care home setting, it should
be brief and not require specialist knowledge or training
to administer. It should have high sensitivity (a low false-
negative rate), and acceptable speciﬁcity (a high true-
negative rate).
Fourteen reviews of delirium assessment instruments
have identiﬁed six externally validated instruments that
may be administered by nursing staff. Of these, two may
have utility as screening tools for delirium in the care
home environment. These are the Delirium Observation
Screening Scale (DOSS)7 and the Nursing Delirium
Screening Scale (NuDESC).8 Sensitivity of the DOSS is
comparable with the NuDESC for detection of delirium
(pooled sensitivity for the DOSS is 92% (95% CIs 74%
to 98% 2 studies, 178 participants) vs 96% for the
NuDESC (95% CI 80% to 100% 1 study, 100 partici-
pants)).9 However, the speciﬁcity of the DOSS is higher
(82% (95% CI 66% to 92%) vs 69% (95% CI 59% to
79%)); therefore, the DOSS was chosen as the candidate
instrument for the study. The DOSS comprises items
which seek objective assessment of the behavioural
aspects of the DSM-IV delirium diagnostic criteria: onset
of a short period of altered consciousness; reduced
ability to focus, sustain or shift attention; a change in
cognition (memory deﬁcit, disorientation, language dis-
turbance); and perceptual disturbance not better
accounted for by a pre-existing, established or evolving
dementia. The DSM also stipulates that, for a diagnosis
of delirium, there is evidence from the clinical assess-
ment that these changes are associated with a general
medical condition and that there is ﬂuctuation during
the course of the day.
The psychometric properties of the DOSS have been
assessed in acute and rehabilitation settings,7 10 but the
utility of the DOSS in care homes has not been evalu-
ated. This study aims to determine how the DOSS per-
forms as a screening instrument for delirium when
administered by care home staff in comparison to a
research standard assessment based on the Confusion
Assessment Method (CAM).11
METHODS AND ANALYSIS
The DOSS study is a prospective observational cohort
study, performed in UK long-term care settings over
24 months (May 2014 to May 2016). The 25-item DOSS,
performed once daily by care home staff, will be mea-
sured against the temporally closest CAM (a research
standard) performed two times per week by research
staff for all participants. Feasibility of routine daily
administration of the DOSS will be investigated by exam-
ining patterns and rates of missing data on care home
staff completed DOSS assessments. To determine the
diagnostic test accuracy of the DOSS, sensitivity, speciﬁ-
city, positive and negative predictive values and likeli-
hood ratios of the DOSS for the detection of delirium
will be calculated. The CAM has been validated as a
measure of delirium severity12 and this will allow for a
further investigation to determine whether the DOSS
may also be used as a measure of delirium severity.
Repeated daily DOSS measurements will be used to
examine the scaling properties of the 25-item DOSS
instrument. Item response theory will be used to deter-
mine whether the questions are measuring the same
underlying constructs (delirium) and whether there are
any redundant questions which may be removed to
create a shorter, care home-speciﬁc DOSS.13
Recruitment
Study sites
Up to four large independent provider care homes
(∼100 residents each) providing residential, nursing or
specialist dementia care for older people in Leeds,
Bradford and York will be eligible as study sites.
Managers of eligible care homes will be approached
regarding participation in the study. Inclusion as a study
site will be based on agreement from the care home
manager to embed the daily measurement of the
25-item DOSS, and to release staff for training sessions
in delirium and administration of the DOSS instrument.
Data on size (numbers of residents and staff), type of
care (residential, nursing or specialist dementia care)
and admission rate per bed will be collected for each
participating care home. Specialist care homes are
excluded unless the specialty is dementia care. Care
homes participating in other studies likely to impact on
delirium incidence (eg, delirium prevention studies) are
also excluded.
Participants
Individuals resident in any of the care home study sites
are eligible to participate in the study. Residents under
65 years are at lower risk of delirium5 and are therefore
excluded from the study. Residents approaching end of
life or in receipt of palliative care (as advised by care
home staff), and those with severe communication difﬁ-
culties (unable to complete the CAM) will be excluded.
Consent procedures
The properties of the DOSS screening instrument are
being tested in a population with a high prevalence of
dementia. It is therefore likely that a signiﬁcant number
of potential participants will lack mental capacity to
provide written informed consent to participate in the
study. It is important that these individuals are not
excluded from participating in the research to ensure
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that the study sample is representative and to maximise
generalisability of the results to those potentially most
likely to beneﬁt from the study ﬁndings.
Residents eligible to participate in the study will be
approached and asked to provide informed consent
through a combined consent–capacity process. Where a
resident lacks capacity to consent to participate in the
study, a declaration for participation will be sought from
a personal consultee in accordance with the Mental
Capacity Act (2005). If no personal consultee is avail-
able, a member of care home staff will be asked to act as
a nominated consultee, acting in the best interests of
the resident and in accordance with any pre-expressed
views or wishes. Capacity may ﬂuctuate during the
course of the study, due to the ﬂuctuating course of
delirium. We will ask potential participants whether they
consent to continue with study assessments in the event
that they subsequently lose capacity. Residents who have
provided this consent will continue in the study unless
there is a clear expressed wish from the resident, a
family member or carer that they wish to withdraw.
Training
Care home staff
Most care home staff will have experience of caring for
residents with delirium but it may not have been identi-
ﬁed as such. Speciﬁc training in delirium will be pro-
vided in interactive small group sessions drawing on the
existing experience of care home staff in recognising
behaviour change in residents with delirium, putting
this into the context of the items of the 25-item DOSS.
Written training manuals will be provided for care home
staff describing delirium and delirium risk factors, the
completion of the DOSS instrument and study proce-
dures. Tests of DOSS inter-rater reliability will be
performed monthly by care home staff.
Research staff
Research assistants will be trained in delirium assessment
according to the methods described in the CAM admin-
istration manual.11 This training will include a scenario-
based delirium detection session using the CAM (and
the CAM-severity scoring methodology). CAM assess-
ments will be performed according to the methodology
outlined in the CAM administration manual.11 Researchers
will be observed performing the CAM assessments in the
care home environment by a consultant geriatrician and
tests of CAM inter-rater reliability will be performed
monthly.
Study assessments
Baseline
The number of residents, type of care home (nursing or
residential) and Care Quality Commission rating will be
recorded for each participating care home.
Data collected for all potentially eligible participants
will include age, sex, an existing dementia diagnosis or a
positive response to the case ﬁnding question used for
the UK National Commissioning for Quality and
Innovation (CQUIN), ‘has the person been more forgetful in
the last 12 months to the extent that it has signiﬁcantly affected
their daily life?’.14 For residents who are subsequently
recruited into the study, a validated screening instru-
ment for cognitive impairment comprising 10 questions,
the Abbreviated Mental Test Score (AMTS), will be per-
formed at baseline.15 A baseline CAM will also be
performed.
Study assessments
Two delirium assessment instruments will be used
throughout the 9 months of the study. These are the
CAM performed two times per week by research staff
and the 25-item DOSS performed once daily by care
home staff, embedded into routine care. In contrast to
the 13-item DOSS, the 25-item DOSS includes beha-
viours which span a full 24-hour period (ie, including
night-time behaviours). If care home staff reﬂect back
on a resident’s behaviour over the course of a shift and
use additional information obtained from care home
records and handovers, it should be possible to identify
whether there have been ﬂuctuations in a resident’s
behaviour without the need to perform more than one
DOSS assessment per day. Care home staff will be
blinded to CAM assessments, and research assistants will
be blinded to DOSS assessments, which will be stored
separately from the care home record. Since symptom
ﬂuctuation is one of the diagnostic criteria for delirium,
testing the sensitivity and speciﬁcity of the DOSS against
the CAM relies on measurements being made close
together such that variation is not falsely attributed to
the instruments. The nearest date and timed DOSS
measurement will be tested against the research
assistant-administered CAM.
CAM assessments
The CAM is an operationalised approach to applying
the DSM delirium criteria. It has been used extensively
in research and, to a lesser extent, in routine care.
Administration takes 5–10 min. The CAM is positive, and
delirium present, if there is sudden onset and a ﬂuctuat-
ing course of inattention and either disorganised think-
ing or an altered conscious level.11 A structured
approach to the identiﬁcation of inattention and disor-
ganised thinking will be adopted as described by
O’Regan et al.16 Inattention will be assessed formally
through the ‘Months of the Year Backwards’ (MOTYB)
test.16 Disorganised thinking will be assessed using the
methods outlined in the CAM administration manual.11
In addition, questions aimed at testing abstract reason-
ing (eg, explaining the meaning of a common proverb)
will be used.16 Scoring of the CAM is described in detail
in the CAM handbook;11 the CAM-severity scoring
system will be adopted to allow the severity of delirium
to be graded.12 The CAM assessments will be entered
electronically into encrypted laptop computers.
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DOSS assessments
The DOSS identiﬁes speciﬁc features of affect or behav-
iour to facilitate recognition of DSM deﬁned criteria for
delirium. The DOSS is based on non-technical observa-
tions from nurses or carers as they attend to patients
during routine care. Only minimal training is required
for administration. This study will examine the 25-item
DOSS rather than the 13-item scale (which is more
weighted towards hyperactive delirium). The hypoactive
delirium subtype has been shown to be twice as common
as hyperactive delirium in the postacute setting17 and is
associated with poor outcomes.18 However, hypoactive
delirium is poorly detected, particularly by nursing staff.19
Methods to improve the detection of hypoactive delirium
by nursing staff in the care home setting are therefore
desirable. The full 25-item DOSS can be completed in
5 min.20 The 25-item DOSS has been shown to have
content validity and internal consistency (Cronbach’s
α 0.93 and 0.96, respectively).7 Concurrent validities
against international standard delirium diagnostic and
severity instruments (the CAM and the Delirium Rating
Scale—Revised—98)7 10 are good. In order to ensure
that the 25-item DOSS is relevant to the UK care home
environment, it has been necessary to reword some
items (eg, to remove reference to interventions that
would not be expected in the care home environment,
eg, intravenous lines).
When the 13-item DOSS was derived from the 25-item
DOSS, the original Likert scoring scale was dichoto-
mised for each item to simply record whether a particu-
lar behaviour has, or has not, been observed during the
course of a shift.21 For this study, each item of the
25-item DOSS will be scored 0 or 1 with a higher score
indicating behaviour more in keeping with delirium
(some items are reverse scored).
Sample size calculation
Measurement of sensitivity of the DOSS requires identiﬁ-
cation of cases where CAM and DOSS are positive.
Sample size calculation is therefore based on the
number of positive delirium episodes (identiﬁed with
the researcher-administered CAM) required to measure
the sensitivity of the DOSS with 95% conﬁdence that the
observed value is within 95% of the true value. Using
the pooled estimate for sensitivity (92%) of the DOSS
from previous studies,9 and the normal approximation
to the binomial proportion distribution, there would
need to be 113 measurements of CAM positive delirium
during the study period.
The study involves repeated assessments; there is
therefore likely to be correlation between serial CAM
measurements. An episode of delirium lasts, on average,
11 days in the long-term care setting.22 CAM measure-
ments are 4 days apart. It is likely that there will be at
least two CAM measurements during each episode of
delirium. We have therefore assumed at least moderate
correlation between CAM measurements (intraclass cor-
relation coefﬁcient of 0.5). Applying an inﬂation factor
(of 1.5) to account for the study design effect due to the
repeated measures would require 170 CAM positive mea-
surements over the 9-month study period. A recent study
of delirium in Canadian long-term care settings offers
the best available estimate of delirium incidence in care
homes of 21.8% in 24 weeks.1 We estimate that 170 CAM
positive readings would be made in 258 residents over
36 weeks.
Data analysis plan
We aim to evaluate the feasibility of embedding the exist-
ing DOSS instrument into routine care rather than to
evaluate the content of the questionnaire. Feasibility of
administration of the DOSS by care home staff will there-
fore be examined through exploring the rates of missing
data, and by examining the intraclass correlation coefﬁ-
cients between staff-administered DOSS assessments.
A receiver operating curve will be plotted to determine
the optimal cut-point for the 25-item DOSS. Sensitivity,
speciﬁcity, positive and negative predictive values, likeli-
hood ratios positive and negative, and a diagnostic OR
will be calculated with 95% conﬁdence limits.
Correlation of the 25-item DOSS with the CAM sever-
ity score will be used to determine whether the DOSS
may be used as a marker of delirium severity.
Item response theory (non-parametric and parametric
if appropriate) will be performed to determine the
scaling properties of the 25-item DOSS and to identify
whether there are any redundant items to form a care
home-speciﬁc version of the DOSS.
ETHICS AND DISSEMINATION
The aim of this study is to identify delirium in a popula-
tion at high risk from the condition. It is likely that this
will increase the diagnosis of delirium in care homes.
This may increase the requirement for medical assess-
ment and input (eg, from general practitioners).
General practitioners will be informed in writing when
one of their patients is recruited into the study. Where a
diagnosis of delirium is made by the research assistant
(with the CAM), the care home manager will be
informed in writing on the same day, such that appropri-
ate action may be taken according to local procedures.
Results of the study will be published in peer-reviewed
scientiﬁc journals. Reports will be prepared for, and
disseminated to, Leeds, Bradford and York Clinical
Commissioning Groups (CCGs), local General
Practitioners, Age UK and the British Geriatrics Society.
Lay summaries will be sent to participant care homes for
dissemination to staff, residents and relatives.
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